Results 101 to 110 of about 1,172 (173)

Changes in bone biological markers after treatment of Iranian diabetic patients with pioglitazone: No relation to polymorphism of PPAR-γ (Pro12Ala)

open access: yesJournal of Research in Medical Sciences, 2013
Background: Thiazolidinediones (TZDs) improves insulin sensitivity by activating the peroxisome proliferator-activated receptor γ (PPAR-g). We aimed to study any association between variation in bone biochemical markers and single nucleotide polymorphism
Fatemeh Namvaran   +5 more
doaj  

PPAR Gamma Receptor: A Novel Target to Improve Morbidity in Preterm Babies. [PDF]

open access: yesPharmaceuticals (Basel), 2023
Victor S   +3 more
europepmc   +1 more source

The role of the PPARG (Pro12Ala) common genetic variant on type 2 diabetes mellitus risk. [PDF]

open access: yesJ Diabetes Metab Disord, 2021
Hashemian L   +4 more
europepmc   +1 more source

Reuniting diabetes through the islet coordinate framework. [PDF]

open access: yesLancet Diabetes Endocrinol
Jagannathan R, Staimez LR, Narayan KMV.
europepmc   +1 more source

Home - About - Disclaimer - Privacy